PhysioWave was founded by a group of Stanford researchers who realized that one of the most meaningful measures of cardiovascular health, Pulse Wave Velocity (PWV), was not in widespread use because it was difficult to obtain. They invented a way to measure PWV in under a minute while a patient is being weighed, with no change to clinical workflow.
Realizing the potential of this technology to identify individuals at high risk of cardiovascular disease, the company developed a clinical product, with a clinically valid home version to follow.
PhysioWave’s mission is to help save millions of people from premature death due to cardiovascular disease.
Marsh Cuttino, M.D.
Emergency and Aerospace Medicine
ApolloMD, EmCare, TEAMHealth
Greg Kovacs, M.D., Ph.D.
CMO at Triple Ring Technologies
EE Professor/MD Stanford (Emeritus)
Judith Swain, M.D.
Former Chair of Stanford Department of Medicine
National Academy of Medicine
Bruce Darling, Ph.D.
EE Professor, University of Washington,
Broad biomedical engineering experience
Laurent Giovangrandi, Ph.D.
Principal Scientist/Engineer at Triple Ring Technologies
Physiologic Research & Algorithms
Previously Stanford, Malibu IQ
External Board Members
25+ years in medical and consumer product
Previously CEO of Miramar Labs, VP & CMO at Align Technology,
GM at Zeiss, Director at General Mills
32+ years in healthcare, consumer electronics, and data communication
President and CEO of Intuity Medical
Previously with Adeza Biomedical, Indesys, Atary
Stanley G. Rockson
- Chief of Consultative Cardiology, Stanford
- Director of the Stanford Center for Lymphatic and Venous Disorders
- Editor-in-Chief of Lymphatic Research and Biology
- Editorial board of Angiology
Glenn M. Chertow
- Division Chief of Nephrology at Stanford
- Research focused on improving care for persons with acute and chronic kidney disease (CKD)
- Formerly served on the faculties of:
- Brigham and Women’s Hospital
- Harvard Medical School
- University of California San Francisco